Home » Topics » BioWorld Science

BioWorld Science
RSS

Banyu discovers new thioredoxin system inhibitor

April 12, 1996

Isis, Ciba-Geigy evaluate antisense drug in phase I

April 12, 1996

BR96 produced successfully in milk from transgenic goats

April 12, 1996

Virulizin clinical trials resume in pancreatic cancer

April 12, 1996

Gastrimmune phase I/II trial completed

April 12, 1996

Corixa in-licenses Optivax delivery system for vaccines

April 12, 1996

Amiprilose advances to phase III in rheumatoid arthritis

April 12, 1996

COX-2 inhibitor research continues at Merck Frosst

April 12, 1996

Virulizin clinical trials reinitiated for KS

April 12, 1996

Cell Genesys to evaluate new gene therapy for AIDS

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...